World Library  
Flag as Inappropriate
Email this Article

Steven Z. Pavletic

Article Id: WHEBN0044223668
Reproduction Date:

Title: Steven Z. Pavletic  
Author: World Heritage Encyclopedia
Language: English
Subject: 1956 births
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Steven Z. Pavletic

Steven Z. Pavletic
Born (1956-01-25)January 25, 1956
Zagreb, Croatia
Alma mater University of Zagreb School of Medicine
Occupation Hematologist, Oncologist

Steven Z. Pavletic (born 25 January 1956) is a Croatian-American physician and researcher in hematology and oncology known for his role in developing consensus guidelines for clinical trials in chronic Graft-versus-host disease (GVHD).[1]

Contents

  • Academic and medical career 1
  • Research and publications 2
  • Awards 3
  • U.S. – Croatia cancer research cooperation 4
  • Other activities 5
  • References 6

Academic and medical career

Pavletic (born Živko Pavletić) was born in Zagreb, Croatia, where he earned his M.D. from the University of Zagreb School of Medicine in 1979. He then completed a clinical fellowship in bone marrow transplantation in 1992 at the Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine in Seattle, Washington.[1] In 1995 he completed an internal medicine residency at the University of Nebraska Medical Center, where he also had hematology and oncology fellowships in 1997.[1] From 1999 until 2002 he was the Director of the Allogeneic Stem Cell Transplantation program at the University of Nebraska.[1]

Currently, he is the Head of the Graft-versus-host disease (GVHD) and Autoimmunity Unit and Senior Clinician at the Experimental Transplantation and Immunology Branch of the Washington, D.C.

Research and publications

Pavletic's main area of research is in the field of hematopoietic stem cell transplantation for hematologic malignancies, chronic Graft-versus-host disease (GVHD) and transplantation for autoimmune disease, with a particular interest in addressing late effects in cancer therapy survivors.[2] He is best known for his research on chronic GVHD, the most common late effect in cancer survivors who underwent allogeneic stem cell transplantations as a form of treatment.[3]

Pavletic's research also includes pioneering work on the use of peripheral blood cells in allogeneic stem cell transplantation as a form of cancer treatment, as opposed to the use of stem cells from the bone marrow.[3]

Pavletic leads a number of clinical trials on chronic GVHD at the National Cancer Institute at NIH.[1][4] He is the chief editor of the first textbook on GVHD entitled “Chronic Graft Versus Host Disease: Interdisciplinary Management”, published in 2009. According to Scopus, Pavletic has published more than 200 articles in peer-reviewed journals. Six articles on a 2005 international consensus project for clinical trials in chronic GVHD were referenced more than 1600 times in peer-reviewed literature.[5]

Awards

In October 2006 Pavletic received the National Cancer Institute (NCI) Director's Individual Merit Award for his achievements in developing national and international consensus guidelines for clinical trials in chronic GVHD,[1] which enabled research to be conducted on one of the most serious late effect cancer treatment complications in already cured patients. Six Croatian print media sources and the Voice of America reported on the award.[3][6][7][8][9][10][11]

U.S. – Croatia cancer research cooperation

Pavletic was recognized in May 2007 by the Croatian Society of Oncology for his efforts at initiating an NIH-European-Croatian expert consortium with the goal of developing strategies for the national cancer control program in Croatia.[2] This cooperation paved the way towards the signing of an agreement in 2010 between the United States and Croatia to foster educational cooperation and training in clinical oncology.[12]

The United States Embassy in Zagreb, Croatia, granted Pavletic a United States Government stipend to spend six weeks at the University Hospital Centre Zagreb, Croatia, in 2013, to assist in the establishment of a multidisciplinary center for the treatment of chronic GVHD resulting from allogeneic stem cell transplantations.[13] In 2013 the Zagreb chronic GVHD team was awarded an international peer-reviewed grant through the Unity Through Knowledge Fund (UKF).[14]

Other activities

Pavletic is president of Hrvatska ura (HURA), a Washington, D.C.-based initiative established in 2010 with the goal of building cultural, economic and scientific ties between the United States and Croatia by working with the Croatian American community.[15] He also serves as vice president of the Association of Croatian American Professionals and is president of its Medicine and Health Sciences Section.[16]

References

  1. ^ a b c d e f g Steven Z. Pavletic – Center for Cancer Research – Staff Pages. Retrieved 20 October 2014. http://ccr.cancer.gov/staff/staff.asp?profileid=8479
  2. ^ a b Herak, J. (2008). Distinguished Croatian Scientists in the World. Zagreb: Croatian-American Society.
  3. ^ a b c “’Transplantacija matičnih krvotvornih stanica promijenila je svijet medicine’ – intervju s prof. dr. Živkom Pavletićem” (in Croatian) (Liječničke novine; page 74; vol. 121; July 2013).
  4. ^ National Cancer Institute Center for Cancer Research – Search CCR Clinical Trials by Selected Physician. Retrieved 20 October 2014. https://bethesdatrials.cancer.gov/clinical-trials-search-physician?field_investigator_name_value=Pavletic
  5. ^ Scopus search. Retrieved 20 October 2014. http://www.elsevier.com/online-tools/scopus
  6. ^ “Američki uspjeh zagrebačkog hematologa”. (in Croatian) (Nacional, 31 October 2006).
  7. ^ Hrvat Pavletić dobio godišnju nagradu američkog Instituta za rak”. (in Croatian) (Večernji list, 26 October 2006).
  8. ^ “Naš liječnik osvojio američku nagradu” (in Croatian) (Novi list, 31 October 2006).
  9. ^ “Američkom Hrvatu nagrada Nacionalnog instituta za rak” (in Croatian) (Slobodna Dalmacija, 27 October 2006).
  10. ^ “Steven Živko Pavletić dobitnik godišnje nagrade Američkog nacionalnog institute za rak”. ba.voanews.com (in Croatian) (Voice of America). Retrieved 20 June 2014. http://ba.voanews.com/content/a-37-2006-10-29-voa7-86025062/1161240.html
  11. ^ “Hrvat dobio nagradu NCI” (in Croatian) (Metro Express, 27 October 2006).
  12. ^ “Potpisan Memorandum o suradnji s Nacionalnim institutom za tumore iz SAD-a”, Ministarstvo znanosti, obrazovanja i sporta (in Croatian). Retrieved 20 June 2014. http://public.mzos.hr/Default.aspx?art=9902&sec=3325
  13. ^ “Dr. Pavletić: Rak treba nestati, o nama ovisi kada”. slobodnadalmacija.hr (in Croatian) (Slobodna Dalmacija). Retrieved 20 June 2014. http://www.slobodnadalmacija.hr/Mozaik/tabid/80/articleType/ArticleView/articleId/214997/Default.aspx
  14. ^ “Prof. dr. sc. Steven Živko Pavletić i prof. dr. sc. Damir Nemet predstavili su svoj UKF projekt na Hrvatskoj radioteleviziji”, Unity Through Knowledge Fund (in Croatian). Retrieved 10 September 2014. http://www.ukf.hr/default.aspx?ID=355
  15. ^ About – Hrvatska ura. Retrieved 20 June 2014.
  16. ^ Executive committee - Association of Croatian American Professionals. Retrieved 10 November 2014. http://www.croampro.com/executive-committee/
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.